NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 130 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,671 | -60.2% | 5,300 | -3.6% | 0.00% | -100.0% |
| Q2 2023 | $14,245 | -12.2% | 5,500 | +38.3% | 0.00% | 0.0% |
| Q1 2023 | $16,222 | -65.3% | 3,976 | -57.3% | 0.00% | -66.7% |
| Q4 2022 | $46,776 | +679.6% | 9,318 | +1664.8% | 0.00% | – |
| Q3 2022 | $6,000 | -92.1% | 528 | -91.1% | 0.00% | -100.0% |
| Q2 2022 | $76,000 | +261.9% | 5,932 | +315.7% | 0.01% | +250.0% |
| Q1 2022 | $21,000 | -77.2% | 1,427 | -72.6% | 0.00% | -71.4% |
| Q4 2021 | $92,000 | +217.2% | 5,200 | +271.4% | 0.01% | +250.0% |
| Q3 2021 | $29,000 | +383.3% | 1,400 | +600.0% | 0.00% | +100.0% |
| Q4 2020 | $6,000 | +500.0% | 200 | +143.9% | 0.00% | – |
| Q2 2020 | $1,000 | – | 82 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,766,666 | $59,928,000 | 49.90% |
| Greenspring Associates, LLC | 1,573,357 | $25,032,000 | 38.95% |
| Svennilson Peter | 18,017,932 | $286,665,000 | 23.39% |
| Aquilo Capital Management, LLC | 1,018,334 | $16,202,000 | 1.72% |
| Jasper Ridge Partners, L.P. | 308,750 | $4,912,000 | 0.28% |
| Samsara BioCapital, LLC | 36,451 | $580,000 | 0.16% |
| Rock Springs Capital Management LP | 360,454 | $5,735,000 | 0.15% |
| Point72 Asset Management, L.P. | 1,611,850 | $25,645,000 | 0.13% |
| Virtus ETF Advisers LLC | 14,880 | $237,000 | 0.12% |
| WELD CAPITAL MANAGEMENT LLC | 15,238 | $242,000 | 0.10% |